Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus. Dermatology Reports, [S. l.], v. 16, n. 3, 2024. DOI: 10.4081/dr.2024.9754. Disponível em: https://journals.pagepress.org/dr/article/view/9754. Acesso em: 19 jun. 2025.